
Christopher Upton
Examiner (ID: 12246, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1776, 1308, 1778, 1724, 1306, 1797 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16298123
[patent_doc_number] => 20200283846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => NONINVASIVE MOLECULAR CONTROLS
[patent_app_type] => utility
[patent_app_number] => 16/082107
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082107 | Noninvasive molecular controls | Mar 5, 2017 | Issued |
Array
(
[id] => 18153325
[patent_doc_number] => 11566290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Purification of RNA fractions using a hydrophilic polymeric material
[patent_app_type] => utility
[patent_app_number] => 16/079035
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 12
[patent_no_of_words] => 20617
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079035 | Purification of RNA fractions using a hydrophilic polymeric material | Feb 27, 2017 | Issued |
Array
(
[id] => 14362701
[patent_doc_number] => 10302645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/443499
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 21848
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443499
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443499 | Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer | Feb 26, 2017 | Issued |
Array
(
[id] => 11744272
[patent_doc_number] => 20170198344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Compositions and Methods for Analyzing Modified Nucleotides'
[patent_app_type] => utility
[patent_app_number] => 15/441431
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14146
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15441431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/441431 | Compositions and methods for analyzing modified nucleotides | Feb 23, 2017 | Issued |
Array
(
[id] => 13987317
[patent_doc_number] => 20190062816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => SINGLE NUCLEOTIDE DETECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/079366
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079366 | SINGLE NUCLEOTIDE DETECTION METHOD | Feb 23, 2017 | Abandoned |
Array
(
[id] => 15268193
[patent_doc_number] => 20190382830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => A SIMPLE ONE-STEP REAL-TIME MOLECULAR SYSTEM FOR MICRORNA DETECTION
[patent_app_type] => utility
[patent_app_number] => 16/079992
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079992 | Simple one-step real-time molecular system for microRNA detection | Feb 23, 2017 | Issued |
Array
(
[id] => 12682177
[patent_doc_number] => 20180119225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => DETECTING 5-HYDROXYMETHYLATED CYTOSINE
[patent_app_type] => utility
[patent_app_number] => 15/440822
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440822 | DETECTING 5-HYDROXYMETHYLATED CYTOSINE | Feb 22, 2017 | Abandoned |
Array
(
[id] => 11692328
[patent_doc_number] => 20170168043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/440284
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 61524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440284 | Selective oxidation of 5-methylcytosine by TET-family proteins | Feb 22, 2017 | Issued |
Array
(
[id] => 11691267
[patent_doc_number] => 20170166980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'THYROID TUMORS IDENTIFIED'
[patent_app_type] => utility
[patent_app_number] => 15/440489
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 45951
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440489 | Thyroid tumors identified | Feb 22, 2017 | Issued |
Array
(
[id] => 13345789
[patent_doc_number] => 20180224434
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-08-09
[patent_title] => MEASURING A LEVEL OF A 5-HYDROXYMETHYLCYTOSINE IN A SAMPLE FROM A SUBJECT HAVING A CANCER OR SUSPECTED OF HAVING CANCER
[patent_app_type] => utility
[patent_app_number] => 15/440826
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440826 | Measuring a level of a 5-hydroxymethylcytosine in a sample from a subject having a cancer or suspected of having cancer | Feb 22, 2017 | Issued |
Array
(
[id] => 11707922
[patent_doc_number] => 20170176421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/440408
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 61510
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440408
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440408 | Detection of 5-hydroxymethylcytosine by glycosylation | Feb 22, 2017 | Issued |
Array
(
[id] => 13345789
[patent_doc_number] => 20180224434
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-08-09
[patent_title] => MEASURING A LEVEL OF A 5-HYDROXYMETHYLCYTOSINE IN A SAMPLE FROM A SUBJECT HAVING A CANCER OR SUSPECTED OF HAVING CANCER
[patent_app_type] => utility
[patent_app_number] => 15/440826
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440826 | Measuring a level of a 5-hydroxymethylcytosine in a sample from a subject having a cancer or suspected of having cancer | Feb 22, 2017 | Issued |
Array
(
[id] => 11707921
[patent_doc_number] => 20170176420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/440319
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 61531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440319 | SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS | Feb 22, 2017 | Abandoned |
Array
(
[id] => 11852093
[patent_doc_number] => 20170226586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Methods for Identifying Subjects with a Genetic Risk for Developing IgA Nephropathy'
[patent_app_type] => utility
[patent_app_number] => 15/437147
[patent_app_country] => US
[patent_app_date] => 2017-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28335
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15437147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/437147 | Methods for identifying subjects with a genetic risk for developing IgA nephropathy | Feb 19, 2017 | Issued |
Array
(
[id] => 11823166
[patent_doc_number] => 20170212103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'METHOD FOR RELATIVE QUANTIFICATION OF NUCLEIC ACID SEQUENCE, EXPRESSION, OR COPY CHANGES, USING COMBINED NUCLEASE, LIGATION, AND POLYMERASE REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/425516
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29557
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425516
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425516 | Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions | Feb 5, 2017 | Issued |
Array
(
[id] => 15102725
[patent_doc_number] => 10472666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => System and method for targeted depletion of nucleic acids
[patent_app_type] => utility
[patent_app_number] => 15/423850
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13905
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/423850 | System and method for targeted depletion of nucleic acids | Feb 2, 2017 | Issued |
Array
(
[id] => 15102725
[patent_doc_number] => 10472666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => System and method for targeted depletion of nucleic acids
[patent_app_type] => utility
[patent_app_number] => 15/423850
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13905
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/423850 | System and method for targeted depletion of nucleic acids | Feb 2, 2017 | Issued |
Array
(
[id] => 15396313
[patent_doc_number] => 10538804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Methods for forensic DNA quantitation
[patent_app_type] => utility
[patent_app_number] => 15/410399
[patent_app_country] => US
[patent_app_date] => 2017-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25031
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15410399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/410399 | Methods for forensic DNA quantitation | Jan 18, 2017 | Issued |
Array
(
[id] => 13717947
[patent_doc_number] => 20170369928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => METHOD FOR EVALUATING DNA DAMAGE FROM ANALYTE
[patent_app_type] => utility
[patent_app_number] => 15/392986
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392986 | METHOD FOR EVALUATING DNA DAMAGE FROM ANALYTE | Dec 27, 2016 | Abandoned |
Array
(
[id] => 12031167
[patent_doc_number] => 20170321266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING'
[patent_app_type] => utility
[patent_app_number] => 15/390806
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23491
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390806
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390806 | ADAPTORS FOR NUCLEIC ACID CONSTRUCTS IN TRANSMEMBRANE SEQUENCING | Dec 26, 2016 | Abandoned |